Position in TRLV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$11,569
New position
Shares Held
1,177
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 125 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HARBOUR INVESTMENTS, INC. holds $1,384,173 across 38 Drug Manufacturers - Specialty & Generic names. TRLV ranks #15 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
13,410 | $464,924 | |
| 2 | VTRS |
Viatris Inc
|
12,765 | $202,708 | |
| 3 | ZTS |
Zoetis Inc.
|
1,991 | $143,073 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
8,036 | $128,817 | |
| 5 | HROW |
Harrow, Inc.
|
1,970 | $83,665 | |
| 6 | HLN |
Haleon plc
|
6,094 | $56,857 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,551 | $52,547 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
91 | $49,306 |
All Filings in TRLV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,569 | 1,177 | Shares | Sole | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||